# Physiologic Assessment Following Gadoxetic Acid and Gadobenate Dimeglumine Administration

> **NCT02226666** · — · COMPLETED · sponsor: **University of Michigan** · enrollment: 107 (actual)

## Conditions studied

- Liver Tumor

## Interventions

- **DRUG:** MRI with Multihance
- **DRUG:** MRI with Eovist

## Key facts

- **NCT ID:** NCT02226666
- **Lead sponsor:** University of Michigan
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2013-08
- **Primary completion:** 2015-12
- **Final completion:** 2015-12
- **Target enrollment:** 107 (ACTUAL)
- **Last updated:** 2017-01-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02226666

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02226666, "Physiologic Assessment Following Gadoxetic Acid and Gadobenate Dimeglumine Administration". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02226666. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*